Anaconda Biomed — Series B (estimated) · €3.6M

CDTI Innovación, through its Innvierte programme, agreed to co-invest €3.6M in neurovascular medtech Anaconda Biomed alongside existing shareholders Ysios Capital and Asabys Partners. The company develops the ANA Funnel Catheter for mechanical thrombectomy in acute ischemic stroke; no overall round size or stage label was disclosed.

Lead not disclosed RoundSeries B (estimated) Announced10 Jan 2025 CitySant Cugat del Vallès SectorHealthtech & Bio · Medtech / Neurovascular devices Source A

Something wrong? Suggest a correction →